“…Developing CBD-ODT represents an opportunity taking into consideration the reduced number of pharmaceutical formulations with CBD that can be found on the market. Other drugs that are already present on the pharmaceutical market or were used to obtain orodispersible tablets are loperamide, sulpiride, desloratadine, loratadine, olanzapine, some of them having also solubility issues just as CBD (desloratadine and loratadine) ( Alejandro et al, 2020 , Tawfeek et al, 2020 , Novick et al, 2017 , Montgomery et al, 2012 ). Taking into consideration the palatability, the use of flavouring and sweetener agents needs to be considered when developing a new formulation ( Desai et al, 2020 , Casian et al, 2018 ).…”